abstract |
The invention provides a novel prostate-specific cell-surface antigen, designated ProstatenStem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostatencancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent andnandrogen-independent prostate tumors. |